Related Experiment Videos
Methylphenidate treatment
1University Children's Hospital, Department of Neuropediatrics, P.O. Box, CH-4005, Basel, Switzerland.
Insights
Methylphenidate is a common ADHD treatment, but its use in children with neurological conditions like epilepsy or brain injuries remains controversial due to limited efficacy and side effect data.
Area of Science:
- Pediatric Neurology
- Child Psychiatry
- Neurodevelopmental Disorders
Background:
- Methylphenidate is a widely prescribed psychostimulant for Attention-Deficit/Hyperactivity Disorder (ADHD).
- Attention deficits are also observed in various childhood neurological diseases.
- The use of methylphenidate in these specific pediatric neurological populations is not well-established and remains a subject of debate.
Purpose of the Study:
- To review the current literature on the efficacy and side effects of methylphenidate in children with specific neurological conditions.
- To highlight the existing gaps in knowledge regarding methylphenidate use in pediatric neurological disorders.
- To encourage further controlled research in this clinical area.
Main Methods:
- Literature review of existing studies on methylphenidate in children with neurological conditions.
- Analysis of available data on efficacy and adverse events.
- Identification of research gaps and controversies.
Main Results:
- Limited data exists on the effectiveness and safety of methylphenidate in children with epilepsy, brain tumors, leukemia, closed brain injury, encephalitis, meningitis, or mental retardation.
- The use of methylphenidate in these populations is controversial.
- Further controlled investigations are needed.
Conclusions:
- The efficacy and side effect profile of methylphenidate in children with various neurological conditions require further investigation.
- Controlled studies are essential to establish appropriate treatment guidelines for methylphenidate in pediatric neurological disorders.
- This review aims to stimulate such necessary future research.
Abstract:
Methylphenidate is the psychotropic drug most commonly used to treat individuals suffering from developmental attention-deficit-hyperactivity disorder. Additional attention deficit is part of numerous neurologic diseases in childhood. Despite the vast extent of scientific research on methylphenidate, the use of this stimulant in the treatment of cognitive and behavioral dysfunction in children with epilepsy, brain tumor, leukemia, closed brain injury, encephalitis, meningitis, or mental retardation continues to be controversial. Only few data exist about the efficacy and side effects of methylphenidate treatment in children with this neurologic illness or history. The aim of the present study is to provide a review of this important clinical topic and perhaps to stimulate further controlled investigations.